Manchester Capital Management LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 100 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Manchester Capital Management LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,325,000
-46.0%
65,7420.0%0.18%
-46.4%
Q2 2021$2,453,000
+45.9%
65,7420.0%0.34%
+35.2%
Q1 2021$1,681,000
+16.1%
65,7420.0%0.25%
+11.6%
Q4 2020$1,448,000
+37.6%
65,742
+12.5%
0.22%
+37.4%
Q3 2020$1,052,000
-12.1%
58,457
+24.0%
0.16%
-0.6%
Q2 2020$1,197,000
+38.2%
47,1430.0%0.16%
+18.0%
Q1 2020$866,000
-16.7%
47,1430.0%0.14%
+23.0%
Q4 2019$1,039,000
+283.4%
47,143
+150.0%
0.11%
+253.1%
Q3 2019$271,000
-8.8%
18,8570.0%0.03%
-15.8%
Q2 2019$297,000
+7.6%
18,8570.0%0.04%
+8.6%
Q1 2019$276,000
+19.5%
18,8570.0%0.04%0.0%
Q4 2018$231,000
-19.8%
18,8570.0%0.04%
-14.6%
Q3 2018$288,000
+24.7%
18,8570.0%0.04%
+17.1%
Q2 2018$231,000
+28.3%
18,8570.0%0.04%
+20.7%
Q1 2018$180,00018,8570.03%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,705,392$43,607,0007.88%
Bain Capital Life Sciences Investors, LLC 3,080,237$78,762,0004.46%
DAFNA Capital Management LLC 587,756$15,029,0003.57%
RTW INVESTMENTS, LP 7,463,291$190,836,0002.98%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$5,114,0002.79%
Evolutionary Tree Capital Management, LLC 122,473$3,132,0001.85%
Parkman Healthcare Partners LLC 303,268$7,755,0001.80%
Eagle Health Investments LP 161,125$4,120,0001.62%
BRIDGER MANAGEMENT, LLC 588,910$15,058,0001.41%
Woodline Partners LP 1,777,000$45,438,0001.01%
View complete list of DICERNA PHARMACEUTICALS INC shareholders